3RND
LIVE

Serial Number

79164322

Owner

AsedaSciences AG

Attorney

Jeffrey A. Smith

Filing Date

Mar 14, 2015

Add to watchlist:

No watchlists yet
View on USPTO

3RND Trademark

Serial Number: 79164322 • Registration: 4943582

3RND is a trademark filed by AsedaSciences AG on March 14, 2015. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

AsedaSciences AG (6 trademarks)

Untere Paulistrasse 6a
Schindellegi CH-8834 , CH

Entity Type: 99

Trademark Details

Filing Date

March 14, 2015

Registration Date

April 26, 2016

Published for Opposition

February 9, 2016

Cancellation Date

March 14, 2025

Goods & Services

[ Database management software; software for application and database integration; software for creating searchable databases; computer application software for mobile phones, cellular phones, handheld computers, smart telephones, PC tablets, personal digital assistants, mobile computers, computers, namely, software used for analysis, storage, data retrieval and visualization of compounds and the cellular effect of compounds in drug discovery; bioinformatics software used to assess the cellular effect of compounds in the drug discovery and development process; computer graphics software; software for accessing information directories that may be downloaded from a global computer network; software for data storage automation; data search software, namely, software for creating searchable database of data; digital image processing software; software for data and document capture, transmission, storage and indexing; scanning software ]

[ Scientific research and development; ] scientific and technological services, namely, novel multi-parametric phenotypic screening in the nature of analytical testing [ services and protein isolation ] for the characterization and simultaneous identification of multiple biological and physiological effects caused by drug candidates on live human cell models in the field of pharmaceutical research, drug discovery and characterization of compound effect [, and scientific research and development relating thereto ] ; Scientific and technological services for scientific analysis, testing and research in the fields of pharmaceutical research, drug discovery and characterization of compound effect [, and protein separation, isolation and characterization ] ; [ scientific research services; ] scientific testing and analysis in the fields of pharmaceutical research, drug discovery and characterization of compound effect [, and protein separation, isolation and characterization ] ; computer-assisted scientific research, testing and analysis services in the fields of pharmaceutical research, drug discovery and characterization of compound effect by using mathematical and statistical algorithms to compare and predict the effect of a target compound to that of an approved drug or known toxin, where a biological fingerprint is created and analyzed by measuring the broad physiological and biological effect of said compounds on live human cells; [ laboratory research and analysis services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, and protein separation, isolation and characterization; pharmaceutical research and development; ] Scientific research and scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds [, and protein separation, isolation and characterization; scientific laboratory services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, and protein separation, isolation and characterization; scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, and protein separation, isolation and characterization; provision of information about medical and scientific research in the field of pharmaceuticals; preparation of reports on scientific research; provision of scientific information on technological research in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; ] provision of scientific information about industrial analysis and research services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; [ provision of information and data relating to medical research and development and veterinary medical research; consultancy services in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics; engineering and ] scientific consultancy services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds [, and protein separation, isolation and characterization; provision of technical advice in the field of scientific and industrial research; consultancy in the field of scientific and industrial research ]

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Oct 10, 2025 DENA
DEATH OF INTERNATIONAL REGISTRATION
Oct 10, 2025 DETH
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Apr 26, 2025 REM4
PARTIAL INVALIDATION PROCESSED BY THE IB
Mar 17, 2024 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Feb 3, 2024 INPS
INVALIDATION PROCESSED
Feb 2, 2024 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 25, 2024 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 25, 2023 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
May 25, 2023 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 16, 2023 APRE
TEAS SECTION 71 RECEIVED
Oct 25, 2022 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 26, 2021 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 12, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 27, 2016 FICS
FINAL DISPOSITION PROCESSED
Jul 27, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 26, 2016 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 26, 2016 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 9, 2016 NPUB
PUBLISHED FOR OPPOSITION
Feb 9, 2016 PUBO
NOTIFICATION PROCESSED BY IB
Feb 5, 2016 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 20, 2016 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 20, 2016 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 20, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 4, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 17, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 17, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 17, 2015 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 17, 2015 CNEA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 29, 2015 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 29, 2015 REAP
REFUSAL PROCESSED BY IB
Jul 11, 2015 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 22, 2015 RFCS
REFUSAL PROCESSED BY MPU
Jun 22, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 19, 2015 RFCR
NON-FINAL ACTION WRITTEN
Jun 18, 2015 CNRT
ASSIGNED TO EXAMINER
Jun 18, 2015 DOCK
APPLICATION FILING RECEIPT MAILED
May 6, 2015 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 2, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 30, 2015 REPR